Darwin AG to Present at Invest 2026 in Stuttgart and the Equity Forum in Frankfurt

Munich, 9 April 2026 — 10:00 CET/CEST

Darwin AG (ISIN DE000A3C35W0) will be participating in two capital markets conferences in spring 2026: the Invest conference in Stuttgart and the Equity Forum (German Spring Conference 2026) in Frankfurt.

The Invest, the leading expo for finance and investment, takes place from April 17 to 18, 2026, at Messe Stuttgart. Guided by the theme “Invest in the Future of Precision Health,” Dr. Daniel Wallerstorfer, CEO of Darwin AG, presented the Company’s equity story on April 17, 2026, at 5:30 p.m. Visitors met the management on-site in Hall 4, Booth 4E32.

The Equity Forum’s 2026 Spring Conference took place from May 11 to 12, 2026, at the Flemings Selection Hotel in Frankfurt. The presentation took place on May 12, 2026, from 9:20 a.m. to 9:55 a.m., followed by one-on-one meetings with Dr. Wallerstorfer.

About Novogenia AG (formerly Darwin AG): The Novogenia Group, headquartered in Munich (Germany), is a European healthcare company, particularly active in the field of human genetics and the development of personalized products based on genetic analysis. The genetic analyses conducted in the company’s own laboratory are used in the diagnosis, treatment, and prevention of diseases, as well as in the production of individually tailored nutritional supplements and cosmetics.

Contact:
Novogenia AG (Investor Relations)
Brienner Str. 7, 80333 Munich
Tel: +49 89 20 500 450
investor.relations@novogenia.com

Originally distributed via EQS News under the company's then-current name, Darwin AG. Source: eqs-news.com (original German-language release).